Table 4.
Indications for DD/TBSP in Patients with Multiple Nevi |
---|
>60 melanocytic nevi |
CDKN2A mutation or other rarer high-risk melanoma genetic variants |
>40 melanocytic nevi and a personal history of melanoma |
>40 melanocytic nevi and red hair and/or a MC1R mutation |
>40 melanocytic nevi and a history of organ transplantation |
* Adapted from Russo et al. [1].